natural history multiple sclerosis study Applications planning interpretation clinical therapeutic trials hypothetical entry criteria typical clinical therapeutic trials patients eligible clinic-based study multiple sclerosis MS London Ontario patients observed frequency deterioration point disability status scale DSS Kurtzke feasible endpoint clinical trials number patients randomized clinical trial significant result alpha power observed rate deterioration linearity DSS frequency progression staying time level DSS frequency progression times levels disability considerable intrapatient interpatient variation time data major implications design conduct clinical therapeutic trials MS 